We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial. Read More
Philip Morris and British American Tobacco (BAT) have entered the race for a COVID-19 vaccine in collaboration with two biotech firms working on plant-based vaccines. Read More
CSIRO was the first research organization outside of China to generate sufficient stock of the virus to enable pre-clinical studies of COVID-19. Read More
A coalition of more than 50 rheumatology and lupus organizations urged all 50 governors in a letter to ensure patient access to chloroquine and hydroxychloroquine, which are used to treat lupus and arthritis, as well as malaria and now COVID-19. Read More